Toggle navigation
Home
Search
Services
Blog
Contact
About
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
Kmt Hepatech, Inc., Edmonton, AB, Canada
Search grants from Kmt Hepatech, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Simultaneous coaxial widefield imaging and reflectance confocal microscopy for improved diagnosis of skin cancers in vivo
Exploring the Core of High Risk Networks
Myocyte Remodeling in Heart Failure
Combination of Growth Factor on Hemolymphopoietic Stem Cells
The Multiple-Minima Problem in Protein Folding
Recently added grants:
Genomic Profiling of T-cell Acute Lymphoblastic Leukemia in Children
Role of Rip2 in the Generation of Pathogenic Th17/Th1 T-cells and Ileitis
Placental Transcriptomics and Risk for Schizophrenia
Effectiveness of metformin for weight control in pediatric patients on SGA
Phage extracellular polysaccharide depolymerases to combat Pseudomonas aeruginosa biofilms
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272201000016I-0-27200001-1
Application #
8539576
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$1,292,503
Indirect Cost
Institution
Name
Kmt Hepatech, Inc.
Department
Type
DUNS #
202499542
City
Edmonton
State
AB
Country
Canada
Zip Code
76 2-E1
Related projects
NIH 2012
N01 AI
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
/ Kmt Hepatech, Inc.
$1,292,503
NIH 2011
N01 AI
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
Kneteman, Norman / Kmt Hepatech, Inc.
$1,260,145
NIH 2010
N01 AI
Animal Models of Infectious Diseases
/
$50,000
Comments
Be the first to comment on this grant